MetaCap

Bio-Techne Earnings

NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

72.53+0.10 (+0.14%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Fiscal period

Sep/2026

EPS estimate

$0.40

Bio-Techne earnings summary

Bio-Techne is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.40. In its most recent report on Aug 24, 2026 (Q4 2026), TECH posted EPS of $0.36. Revenue for the quarter was $321.2 million.

Across the last 16 reports, TECH shares moved an average of 5.0% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

TECH earnings history

Bio-Techne reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 24, 2026—$0.36—+0.1%
May 6, 2026—$0.32—-10.5%
Feb 4, 2026—$0.24—-10.3%
Nov 5, 2025—$0.24—+3.4%
Aug 22, 2025—$-0.11—-4.3%
May 8, 2025—$0.14—-1.6%
Feb 6, 2025—$0.22—-9.4%
Nov 5, 2024—$0.21—-11.0%
Aug 22, 2024—$0.26—+2.4%
May 6, 2024—$0.31—+3.6%
Feb 7, 2024—$0.17—+5.4%
Nov 7, 2023—$0.31—+6.2%
Aug 23, 2023—$0.47—-1.7%
May 8, 2023—$0.43—+3.2%
Feb 7, 2023—$0.31—-0.4%
Nov 7, 2022—$0.55—-6.1%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related